Fragment-Based Drug Discovery
Abstract
ADVERTISEMENT RETURN TO ISSUEPerspectiveNEXTFragment-Based Drug DiscoveryDaniel A. Erlanson, Robert S. McDowell, and Tom O'BrienView Author Information Sunesis Pharmaceuticals, Inc., 341 Oyster Point Boulevard, South San Francisco, California 94080 Cite this: J. Med. Chem. 2004, 47, 14, 3463–3482Publication Date (Web):June 4, 2004Publication History Received11 February 2004Published online4 June 2004Published inissue 1 July 2004https://doi.org/10.1021/jm040031vCopyright © 2004 American Chemical SocietyRIGHTS & PERMISSIONSArticle Views12065Altmetric-Citations497LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all…
Citation impact
- FWCI
- 28.92
- Percentile
- 100%
- References
- 116
Authors
3- DADaniel A. ErlansonCorresponding
Sunesis (United States)
- RSRobert S. McDowell
Sunesis (United States)
- TOTom O'Brien
Sunesis (United States)
Topics & keywords
- Citation
- Computer science
- Social media
- Information retrieval
- Icon
- Library science
- Point (geometry)
- Drug discovery